Quantbot Technologies LP Boosts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Quantbot Technologies LP increased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 121.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 135,262 shares of the company's stock after buying an additional 74,126 shares during the quarter. Quantbot Technologies LP owned about 0.05% of Oscar Health worth $1,818,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Arizona State Retirement System raised its position in shares of Oscar Health by 3.1% during the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock worth $644,000 after purchasing an additional 1,454 shares during the period. Xponance Inc. increased its stake in Oscar Health by 12.9% during the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after purchasing an additional 1,649 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Oscar Health by 9.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock worth $561,000 after buying an additional 2,236 shares during the last quarter. KBC Group NV lifted its stake in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its holdings in shares of Oscar Health by 20.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 17,896 shares of the company's stock valued at $241,000 after buying an additional 3,040 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on OSCR shares. Jefferies Financial Group began coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price target on the stock. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $20.21.

Oscar Health Stock Performance

NYSE:OSCR traded down $0.31 during trading on Thursday, reaching $13.45. The company's stock had a trading volume of 2,297,416 shares, compared to its average volume of 3,657,143. Oscar Health, Inc. has a 12 month low of $12.43 and a 12 month high of $23.79. The firm has a market cap of $3.37 billion, a price-to-earnings ratio of -672.01 and a beta of 1.75. The firm has a 50 day moving average of $14.99 and a 200-day moving average of $16.14. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.